Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Work In Process (2023 - 2024)

Historic Work In Process for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q4 2024 value amounting to $4.6 million.

  • Zhengye Biotechnology Holding's Work In Process fell 131.32% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.6 million, marking a year-over-year decrease of 131.32%. This contributed to the annual value of $4.5 million for FY2024, which is 468.69% down from last year.
  • Zhengye Biotechnology Holding's Work In Process amounted to $4.6 million in Q4 2024, which was down 131.32% from $4.7 million recorded in Q4 2023.
  • Zhengye Biotechnology Holding's 5-year Work In Process high stood at $4.7 million for Q4 2023, and its period low was $4.6 million during Q4 2024.